ImmunologybioRxivPreprint
Comprehensive immune profiling of melanoma-draining lymph nodes identifies plasmacytoid dendritic cells as new biomarker for PD-L1 blockade
Emma Reynaud, Sonya Belherazem, Özge Cicek Sener…·Lothar C. Dieterich
The paper identifies plasmacytoid dendritic cells (pDCs) in tumor-draining lymph nodes as a potential biomarker for predicting response to PD-L1 blockade therapy in melanoma.